Substantia Nigra (metabolism) < Substantia Nigra (pathology) < Substantia Nigra (physiology)

Facettes :

List of bibliographic references indexed by Substantia Nigra (pathology)

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000120 (2017)	Candace H. Carriere [Canada] ; Na Hyea Kang [Canada] ; Lennard P. Niles [Canada]	Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.
000153 (2016)	Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]	Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000163 (2016)	Musleh A. Algarni [Canada] ; A Jon Stoessl [Canada]	The role of biomarkers and imaging in Parkinson's disease.
000350 (2016)	Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Richard Camicioli [Canada] ; W R Wayne Martin [Canada]	Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging.
000587 (2015)	Abid Oueslati [Suisse, Canada] ; Blaise Lovisa [Suisse] ; John Perrin [Suisse] ; Georges Wagnières [Suisse] ; Hubert Van Den Bergh [Suisse] ; Yanik Tardy [Suisse] ; Hilal A. Lashuel [Suisse, Qatar]	Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease
000623 (2015)	Ali H. Rajput [Canada] ; Michele L. Rajput [Canada] ; Christopher A. Robinson [Canada] ; Alex Rajput [Canada]	Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations.
000630 (2015)	Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput	Neuroleptic‐induced Parkinsonism: Clinicopathological study
000985 (2014)	Jackalina M. Van Kampen [Canada] ; David B. Baranowski [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay	Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease.
000987 (2014)	Krithika Muthukumaran [Canada] ; Samantha Leahy [Canada] ; Kate Harrison [Canada] ; Marianna Sikorska [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Corrine Keshan [Canada] ; Daniel Lopatin [Canada] ; Harvey Miller [Canada] ; Henryk Borowy-Borowski [Canada] ; Patricia Lanthier [Canada] ; Shelly Weinstock [États-Unis] ; Siyaram Pandey [Canada]	Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease
000993 (2014)	C H Carriere [Canada] ; N H Kang [Canada] ; L P Niles [Canada]	Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
000A24 (2014)	Yiming Xiao [Canada] ; Pierre Jannin ; Tiziano D'Albis ; Nicolas Guizard ; Claire Haegelen ; Florent Lalys ; Marc Vérin ; D Louis Collins	Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA-based analysis.
000B73 (2014)	Panojot Bifsha [Canada] ; Jianqi Yang [États-Unis] ; Rory A. Fisher [États-Unis] ; Jacques Drouin [Canada]	Rgs6 is Required for Adult Maintenance of Dopaminergic Neurons in the Ventral Substantia Nigra
000C37 (2013)	Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. Sadikot	The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
001143 (2012)	Ronald B. Postuma [Canada] ; Jean-Francois Gagnon ; Jacques Y. Montplaisir	REM sleep behavior disorder: from dreams to neurodegeneration.
001145 (2012)	Maxime W. C. Rousseaux ; Paul C. Marcogliese ; Dianbo Qu ; Sarah J. Hewitt ; Sarah Seang ; Raymond H. Kim ; Ruth S. Slack ; Michael G. Schlossmacher ; Diane C. Lagace ; Tak W. Mak ; David S. Park [Corée du Sud]	Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease
001610 (2011)	James B. Koprich ; Tom H. Johnston ; Philippe Huot ; M. Gabriela Reyes ; Maria Espinosa ; Jonathan M. Brotchie	Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
001C79 (2010)	Martin Parent [Canada] ; André Parent [Canada]	Substantia Nigra and Parkinson's Disease: A Brief History of Their Long and Intimate Relationship
001D83 (2009)	W R Wayne Martin [Canada]	Quantitative estimation of regional brain iron with magnetic resonance imaging.
001E53 (2009)	G. Biju [Canada] ; R. De La Fuente-Fernández	Dopaminergic function and progression of Parkinson's disease: PET findings.
002317 (2008)	Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]	Glial reactions in Parkinson's disease
002426 (2007)	Anthony E. Lang [Canada]	The progression of Parkinson disease: a hypothesis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Substantia Nigra (pathology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Substantia Nigra (pathology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Substantia Nigra (pathology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022